|
1
|
Rivera MP, Mehta AC and Wahidi MM:
Establishing the diagnosis of lung cancer: Diagnosis and management
of lung cancer, 3rd Ed: American college of chest physicians
evidence-based clinical practice guidelines. Chest. 143 Suppl
5:e142S–e165S. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reichenberger F, Weber J, Tamm M, Bolliger
CT, Dalquen P, Perruchoud AP and Solèr M: The value of
transbronchial needle aspiration in the diagnosis of peripheral
pulmonary lesions. Chest. 116:704–708. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Buccheri G, Barberis P and Delfino MS:
Diagnostic, morphologic, and histopathologic correlates in
bronchogenic carcinoma. A review of 1,045 bronchoscopic
examinations. Chest. 99:809–814. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Smith MA, Battafarano RJ, Meyers BF, Zoole
JB, Cooper JD and Patterson GA: Prevalence of benign disease in
patients undergoing resection for suspected lung cancer. Ann Thorac
Surg. 81:1824–1828. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wiener RS, Wiener DC and Gould MK: Risks
of transthoracic needle biopsy: How high? Clin Pulm Med. 20:29–35.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gould MK, Donington J, Lynch WR, Mazzone
PJ, Midthun DE, Naidich DP and Wiener RS: Evaluation of individuals
with pulmonary nodules: When is it lung cancer? Diagnosis and
management of lung cancer, 3rd Ed: American college of chest
physicians evidence-based clinical practice guidelines. Chest. 143
Suppl 5:e93S–e120S. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hulpiau P and van Roy F: Molecular
evolution of the cadherin superfamily. Int J Biochem Cell Biol.
41:349–369. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dang Z, Shangguan J, Zhang C, Hu P, Ren Y,
Lv Z, Xiang H and Wang X: Loss of protocadherin-17(PCDH-17)
promotes metastasis and invasion through hyperactivation of
EGFR/MEK/ERK signaling pathway in hepatocellular carcinoma. Tumour
Biol. 37:2527–2535. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen T, Long B, Ren G, Xiang T, Li L, Wang
Z, He Y, Zeng Q, Hong S and Hu G: Protocadherin20 acts as a tumor
suppressor gene: Epigenetic inactivation in nasopharyngeal
carcinoma. J Cell Biochem. 116:1766–1775. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu Q and Maniatis T: A striking
organization of a large family of human neural cadherin-like cell
adhesion genes. Cell. 97:779–790. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dallosso AR, Hancock AL, Szemes M,
Moorwood K, Chilukamarri L, Tsai HH, Sarkar A, Barasch J,
Vuononvirta R, Jones C, et al: Frequent long-range epigenetic
silencing of protocadherin gene clusters on chromosome 5q31 in
Wilms' tumor. PLoS Genet. 5:e10007452009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Taylor KH, Pena-Hernandez KE, Davis JW,
Arthur GL, Duff DJ, Shi H, Rahmatpanah FB, Sjahputera O and
Caldwell CW: Large-scale CpG methylation analysis identifies novel
candidate genes and reveals methylation hotspots in acute
lymphoblastic leukemia. Cancer Res. 67:2617–2625. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu Y, Lemon W, Liu PY, Yi Y, Morrison C,
Yang P, Sun Z, Szoke J, Gerald WL, Watson M, et al: A gene
expression signature predicts survival of patients with stage I
non-small cell lung cancer. PLoS Med. 3:e4672006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
An SW, Moon YH, Oh TJ, Lee MK, Lee CH, Lee
SY and Lee SH: Identification of hypermethylation of PCDHGA12 gene
by genome-wide analysis as a novel diagnostic marker of lung
cancer. Proc Am Assoc Cancer Res (AACR Annual Meeting).
69:33572009.
|
|
15
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC cancer staging manual. 7th edition.
Springer; New York, NY: 2010
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eads CA, Lord RV, Wickramasinghe K, Long
TI, Kurumboor SK, Bernstein L, Peters JH, DeMeester SR, DeMeester
TR, Skinner KA and Laird PW: Epigenetic patterns in the progression
of esophageal adenocarcinoma. Cancer Res. 61:3410–3418.
2001.PubMed/NCBI
|
|
18
|
Langevin SM, Kratzke RA and Kelsey KT:
Epigenetics of lung cancer. Transl Res. 165:74–90. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang L, Yao J, Sun H, He K, Tong D, Song T
and Huang C: MicroRNA-101 suppresses progression of lung cancer
through the PTEN/AKT signaling pathway by targeting DNA
methyltransferase 3A. Oncol Lett. 13:329–338. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhong Z, Ye Y, Guo W, He Y and Hu W:
Relationship between DLK1 gene promoter region DNA methylation and
non-small cell lung cancer biological behavior. Oncol Lett.
13:4123–4126. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Duppel U, Woenckhaus M, Schulz C, Merk J
and Dietmaier W: Quantitative detection of TUSC3 promoter
methylation-a potential biomarker for prognosis in lung cancer.
Oncol Lett. 12:3004–3012. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Czarnecka KH, Migdalska-Sęk M, Domańska D,
Pastuszak-Lewandoska D, Dutkowska A, Kordiak J, Nawrot E,
Kiszałkiewicz J, Antczak A and Brzeziańska-Lasota E: FHIT promoter
methylation status, low protein and high mRNA levels in patients
with non-small cell lung cancer. Int J Oncol. 49:1175–1184. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang MX, Wang HY, Zhao X, Srilatha N,
Zheng D, Shi H, Ning J, Duff DJ, Taylor KH, Gruner BA and Caldwell
CW: Molecular detection of B-cell neoplasms by specific DNA
methylation biomarkers. Int J Clin Exp Pathol. 3:265–279.
2010.PubMed/NCBI
|
|
24
|
Reinert T, Modin C, Castano FM, Lamy P,
Wojdacz TK, Hansen LL, Wiuf C, Borre M, Dyrskjøt L and Orntoft TF:
Comprehensive genome methylation analysis in bladder cancer:
Identification and validation of novel methylated genes and
application of these as urinary tumor markers. Clin Cancer Res.
17:5582–5592. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Girard P, Caliandro R, Seguin-Givelet A,
Lenoir S, Gossot D, Validire P and Stern JB: Sensitivity of
cytology specimens from bronchial aspirate or washing during
bronchoscopy in the diagnosis of lung malignancies: An update. Clin
Lung Cancer. 18:512–518. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Funahashi A, Browne TK, Houser WC and
Hranicka LJ: Diagnostic value of bronchial aspirate and
postbronchoscopic sputum in fiberoptic bronchoscopy. Chest.
76:514–517. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jones AM, Hanson IM, Armstrong GR and
O'Driscoll BR: Value and accuracy of cytology in addition to
histology in the diagnosis of lung cancer at flexible bronchoscopy.
Respir Med. 95:374–378. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Idowu MO and Powers CN: Lung cancer
cytology: Potential pitfalls and mimics-a review. Int J Clin Exp
Pathol. 3:367–385. 2010.PubMed/NCBI
|
|
29
|
Hajdu SI and Melamed MR: Limitations of
aspiration cytology in the diagnosis of primary neoplasms. Acta
Cytol. 28:337–345. 1984.PubMed/NCBI
|
|
30
|
Rao S, Lal A, Barathi G, Dhanasekar T and
Duvuru P: Bronchial wash cytology: A study on morphology and
morphometry. J Cytol. 31:63–67. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Suzuki M and Yoshino I: Aberrant
methylation in non-small cell lung cancer. Surg Today. 40:602–607.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kadara H and Wistuba II: Field
cancerization in non-small cell lung cancer: Implications in
disease pathogenesis. Proc Am Thorac Soc. 9:38–42. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Whitney DH, Elashoff MR, Porta-Smith K,
Gower AC, Vachani A, Ferguson JS, Silvestri GA, Brody JS, Lenburg
ME and Spira A: Derivation of a bronchial genomic classifier for
lung cancer in a prospective study of patients undergoing
diagnostic bronchoscopy. BMC Med Genomics. 8:182015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Silvestri GA, Vachani A, Whitney D,
Elashoff M, Smith Porta K, Ferguson JS, Parsons E, Mitra N, Brody
J, Lenburg ME, et al: A bronchial genomic classifier for the
diagnostic evaluation of lung cancer. N Engl J Med. 373:243–251.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Uribarri M, Hormaeche I, Zalacain R,
Lopez-Vivanco G, Martinez A, Nagore D and Ruiz-Argüello MB: A new
biomarker panel in bronchoalveolar lavage for an improved lung
cancer diagnosis. J Thorac Oncol. 9:1504–1512. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Allione A, Marcon F, Fiorito G, Guarrera
S, Siniscalchi E, Zijno A, Crebelli R and Matullo G: Novel
epigenetic changes unveiled by monozygotic twins discordant for
smoking habits. PLoS One. 10:e01282652015. View Article : Google Scholar : PubMed/NCBI
|
